Monograph Capital Holdings Advisors, LLC 13D and 13G filings for UroGen Pharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-09 7:19 pm Sale | 2025-06-05 | 13D | UROGEN PHARMA LTD URGN | Monograph Capital Holdings Advisors, LLC | 838,615 1.900% | -823,712 (-49.55%) | Filing |
| 2023-08-04 08:56 am Purchase | 2023-07-26 | 13D | UROGEN PHARMA LTD URGN | Monograph Capital Holdings Advisors, LLC | 1,662,327 5.400% | 1,662,327 (New Position) | Filing |